Weiss Multi-Strategy Advisers’s Bio-Techne TECH Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-35,653	Closed	-$2.65M	–	754
2023 Q1	$2.65M	Buy	+35,653	New	+$2.75M	0.06%	374
2022 Q4	–	Sell	-85,000	Closed	-$6.04M	–	727
2022 Q3	$6.04M	Buy	+85,000	New	+$7.34M	0.16%	204
2014 Q2	–	Sell	-9,720	Closed	-$207K	–	915
2014 Q1	$207K	Sell	9,720 -640	-6%	-$14.4K	﹤0.01%	911
2013 Q4	$245K	Sell	10,360 -3,960	-28%	-$85.8K	0.01%	863
2013 Q3	$287K	Buy	+14,320	New	+$272K	0.01%	656

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Weiss Multi-Strategy Advisers's TECH Position: Q2 2023 in Review

Weiss Multi-Strategy Advisers sold out of Bio-Techne (TECH) in Q2 2023, closing a stake of 35,653 shares — an estimated $2.65M sold.

Weiss Multi-Strategy Advisers first reported a position in TECH in Q3 2013 and held it in 5 quarters. The position peaked at $6.04M in Q3 2022. 529 funds tracked by Wall St. Rank hold TECH as of Q2 2023.

Weiss Multi-Strategy Advisers reported no remaining Bio-Techne position as of Q2 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 35,653 Bio-Techne shares in Q2 2023, an estimated $2.65M.
Weiss Multi-Strategy Advisers first reported a position in Bio-Techne in Q3 2013 and held it in 5 quarters.
Weiss Multi-Strategy Advisers's Bio-Techne position peaked at $6.04M in Q3 2022.
529 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.